Saudi GazetteKFSHRC successfully performs liver transplantation surgeriesSaudi GazetteResearch and advances in surgical procedures have revolutionized liver transplantation and have cut in half the waiting period that patients may have to endure until …
11 Diet Foods for CKD – Chronic Kidney Disease Diet ManagementSBWire (press release)There are several benefits people with kidney disease should aim for when planning a natural diet and foods for ckd, which is known as chronic kidney disease. Such a di…
|
TOPCAT: Spironolactone cuts hospitalizations for diastolic heart failure
Family Practice News Digital Network DALLAS – Spironolactone did not hit a home run in the large international “treatment of preserved cardiac function heart failure with an aldosterone antagonist” (TOPCAT) trial, but it did knock out a solid single in the form of significantly reduced … |
|
Remission reinduction with rituximab a possibility for ANCA-associated vasculitis
Skin and Allergy News Digital Network SAN DIEGO – Retreatment of granulomatosis with polyangiitis or microscopic polyangiitis with rituximab may be safe and effective in reinducing remission, a prospective trial has shown. “The vast majority of patients with ANCA [antineutrophil … |
Heart failure patients receiving LVAD may benefit from injection of powerful …News-Medical.netA multicenter team of researchers within the NIH-funded Cardiothoracic Surgical Trials Network (CTSN), led by Icahn School of Medicine at Mount Sinai, have …
|
New lungs, new life for Marystown man
CBC.ca Frank Byrne of Marystown says he has a new lease on life and a message to share following double lung transplant surgery in Toronto. “When you go up there and you see so many people waiting for liver transplants and heart transplants and kidneys and … |
|
Long-Lasting Gene Therapy Benefits Advanced Heart Failure Patients
Science Daily (press release) 19, 2013 — Researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai reported the long-term benefits of a single dose of their gene therapy AAV1/SERCA2a in advanced heart failure patients on Nov. 19 at the … |
Ekf Diagnostics Holding PLC : 19 November 2013. EKF Diagnostics Acute …4-traders (press release)EKF Diagnostics Holdings plc, the AIM listed point-of-care diagnostics business, announces that the development of a Point of Care platform for Acute Kidn…
|
Janssen Oncology Data to be Presented at 2013 American Society of …
Business Wire (press release) Combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP): updated results from a phase 1b study in treatment-naïve patients with CD20-positive B-cell non-Hodgkin’s lymphoma (NHL). (Abstract 852). |
Science Codex |
Heart failure patients receiving LVAD benefit from injection of millions of …
News-Medical.net A multicenter team of researchers within the NIH-funded Cardiothoracic Surgical Trials Network (CTSN), led by Icahn School of Medicine at Mount Sinai, have found end-stage heart failure patients who receive a surgically implanted left ventricular … Mesoblast’s Cell Therapy Strengthens Native Heart Function In Patients With …GlobeNewswire (press release) |